Defiance Daily Target 2X Short LLY ETF

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Wellgistics Health

Huachen AI Parking Management Tech

GeoVax Labs

Sunshine Biopharma

AIM ImmunoTech

Virax Biolabs

NextNRG

GCT Semiconductor

LABU

LLYX

LLYZ

The U.S. Supreme Court has rejected Eli Lilly's appeal regarding a $194 million whistleblower judgment for underpaying Medicaid rebates by misreporting drug pricing. The decision upholds the federal False Claims Act, allowing private individuals to sue on behalf of the government. Eli Lilly's stock fell 1.64% to $988.42 following the ruling, with the company arguing that the whistleblower's claims were unfounded and that its pricing practices were industry-standard.

Fidelity

Eli Lilly

Direxion S&P Biotech Bull 3X

VG Health

Defiance Daily Target 2X Long LLY ETF

SPDR S&P Biotech

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

iShares US Pharma

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

S&P 500

Ondas

Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case

ELIL

LABD

Eli Lilly was among the pharmaceutical companies denied certiorari by the Supreme Court, which rejected multiple appeals related to healthcare and commercial cases. This decision diminishes the chances of immediate Supreme Court intervention in these matters. Following the news, Eli Lilly's shares fell by 2.2% to $985.25.

fidelity

Invesco Nasdaq Biotechnology ETF

Health Care Select Sector SPDR

ALPS Medical Breakthrough

Direxion Daily LLY Bear 1X Shares

Ark Genomic Revolution ETF

Direxion Daily LLY Bull 2X Shares

Direxion S&P Biotech Bear 3X

iShares Global Healthcare

Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals

Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference | LLY Stock News

StockTitan

AllianceBernstein

Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference | LLY Stock News

Representative Byron Donalds (Republican-Florida) purchased shares of Eli Lilly and Company (NYSE: LLY) valued between $1,001 and $15,000 on April 2nd, as disclosed in a filing on May 13th. The stock has seen a recent decline, trading down $1.51 to $1,005.20. Eli Lilly reported strong quarterly earnings, beating estimates with $8.55 EPS and $19.80 billion in revenue, and declared a quarterly dividend of $1.73 per share.

Market Beat

Novo Nordisk AS

Hims & Hers Health

Chipotle Mexican Grill

Intuit

Marvell Tech

Netflix

Trade Desk

Paypal

Viking Therap

Daiwa Securities Group Inc.

Barclays

Eli Lilly and Company (NYSE:LLY) Stock Acquired Rep. Byron Donalds

Eli Lilly and Company (NYSE: LLY) and UNICEF USA have launched a six-year initiative on May 14, 2026, in New York and Indianapolis to enhance prevention and care for non-communicable diseases in children residing in low- and middle-income countries. This partnership seeks to address the pressing issue by leveraging resources and expertise, with the goal of significantly impacting the lives of children in need.

Unusual Whales

Lilly and UNICEF collaborate to give millions of children a healthier start

GOOG

GOOGL

GGLL

Thrive Capital and Alphabet are leading a $2 billion fundraising effort for Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind. Founded in 2021 by Demis Hassabis, Isomorphic aims to revolutionize pharmaceuticals through machine learning. The company has secured strategic partnerships with Novartis, Eli Lilly, and Johnson & Johnson. Thrive Capital, managing over $50 billion in assets, has previously invested in notable firms like SpaceX and OpenAI.

- Thrive Capital and Alphabet are leading a new financing effort for Isomorphic Labs, which specializes in AI-driven drug discovery.  
- The London-based company aims to raise $2 billion for global expansion and has formed significant partnerships with Novartis, Eli Lilly, and Johnson & Johnson.  
- Isomorphic, founded by DeepMind co-founder Demis Hassabis in 2021, previously raised $600 million in a funding round led by Thrive Capital.

benzinga_article

Johnson & Johnson

Alphabet - C

Novartis AG

Alphabet

Direxion Daily GOOGL Bull 2X Shares

NOVARTIS AG

New York Times

Disney

Stripe

OpenAI

Brookfield Asset

Apollo Global

APOLLO GLOBAL MANAGEMENT INC 6.75% CONV PFD STK SER A

Apollo Global Management Pref Share APO 7.625 09/15/53

Thrive Capital, Alphabet To Lead Isomorphic Labs $2 Billion Fundraising Goal

Eli Lilly has launched a new ad campaign featuring Indiana Fever's Caitlin Clark, focusing on health and sports under the tagline "Start How You Can." The 60-second ad showcases everyday people engaging in physical activities, emphasizing that health journeys begin with small steps. Senior VP Lina Polimeni highlighted the campaign's aim to shift the conversation from reactive to proactive health. The campaign coincides with the WNBA season opener and will continue through major sports events, aiming to keep the dialogue on health ongoing throughout the year.

Fiercepharma

Pfizer

Eli Lilly shoots for health in new Caitlin Clark ad campaign

Eli Lilly (NYSE: LLY) has raised $9 billion in bonds to fund nearly $15 billion in acquisitions and a significant manufacturing expansion, particularly in Indiana for genetic medicines and obesity drugs. The company is focusing on a larger drug pipeline and US production, while its stock has risen 30.7% over the past year. However, concerns arise from FDA scrutiny of Foundayo due to a serious liver adverse event. Investors should monitor the impact of this spending and regulatory developments on Eli Lilly's market position.

Simplywall

Eli Lilly Ramps Up US Growth Plans As Foundayo Risks Draw Focus

NVDL

SOXL

SOXX

Today's stock market shows a divergence with tech stocks rallying while healthcare struggles. The technology sector, led by Apple (up 2.25%) and Nvidia (up 1.69%), reflects strong investor confidence. In contrast, healthcare stocks like Eli Lilly (down 1.79%) and Gilead Sciences (down 1.98%) face challenges. Consumer cyclical and defensive sectors remain stable, with Amazon and Walmart showing gains. The financial sector presents mixed signals. Investors are advised to bolster tech holdings and monitor healthcare for potential recovery opportunities.

- The stock market shows a split trend with the technology sector rallying while healthcare stocks decline.  
- Technology leaders like Apple and Nvidia recorded gains, reflecting increased investor confidence, whereas Eli Lilly and Gilead Sciences struggled amidst sector-specific pressures.  
- Investors are advised to strengthen technology holdings while monitoring healthcare for potential recovery, and consider diversifying across defensive and cyclical sectors for stability.

Investinglive

GraniteShares 2x Long NVDA Daily ETF

Direxion Semicon Bull 3X

iShares Semiconductor ETF

T-Rex 2X Long Apple Daily Target ETF

Invesco S&P 500 Equal Weight Tech ETF

iShares Expanded Tech Software Sector ETF

T-Rex 2X Long NVIDIA Daily Target ETF

Direxion Daily AMZN Bull 2X Shares

GraniteShares 2x Long AAPL Daily ETF

Global X E-commerce ETF

GraniteShares 2x Long AMZN Daily ETF

Direxion Daily NVDA Bear 1X ETF

Direxion Daily AAPL Bear 1x Shares

Global X Data Center & Dgtl Infrs ETF

ProShares Online Retail

Roundhill AMZN WeeklyPay ETF

YieldMax NVDA Option Income Strategy ETF

Proshares UltraPro QQQ

VanEck Semiconductor ETF

Apple

NVIDIA

Microsoft

Broadcom

Gilead Sciences

Amazon

Walmart

PepsiCo

JPMorgan Chase

Citigroup

NVIDIA Corporation

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Tech stocks rally while healthcare drags: Today's market highlights

Dividend Roundup: Eli Lilly, PepsiCo, Apple, Visa, and more

businessinsider

Visa

SPDR FD Consumer Staples

Parametric Equity Plus ETF

iShares US Consumer Staples ETF

Direxion Daily AAPL Bull 2X Shares

VG Consumer Stap

Dividend Roundup: Eli Lilly, PepsiCo, Apple, Visa, and more

Defiance Daily Target 2X Short LLY ETF(LLYZ.US)

Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case

Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals

Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference | LLY Stock News

Eli Lilly and Company (NYSE:LLY) Stock Acquired Rep. Byron Donalds

Lilly and UNICEF collaborate to give millions of children a healthier start